Literature DB >> 32343358

Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.

Adriana Tamburello1, Marco Marando1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32343358     DOI： 10.4414/smw.2020.20264

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN： 0036-7672            Impact factor:   2.193


× No keyword cloud information.
  10 in total

1.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

2.  [Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence].

Authors:  Emil C Reisinger; Ronald von Possel; Philipp Warnke; Hilte F Geerdes-Fenge; Christoph J Hemmer; Susanne Pfefferle; Micha Löbermann; Martina Littmann; Petra Emmerich
Journal:  Dtsch Med Wochenschr       Date:  2020-06-22       Impact factor: 0.628

3.  COVID-19 and Pulmonary Embolism: Not a Coincidence.

Authors:  Adriana Tamburello; Giovanni Bruno; Marco Marando
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-04

Review 4.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

5.  Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial.

Authors:  Faryal Khamis; Zainab Al Arimi; Hamed Al Naamani; Maher Al Bahrani; Nenad Pandak; Zakaryia Al Bolushi; Stephan S Deenadayalan; Adil Al Lawati; Issa Al Salmi; Ibrahim Al-Zakwani
Journal:  Oman Med J       Date:  2021-09-30

Review 6.  Perplexing issues for convalescent immune plasma therapy in COVID-19.

Authors:  Oner Ozdemir
Journal:  North Clin Istanb       Date:  2021-11-15

Review 7.  COVID-19: benefits and risks of passive immunotherapeutics.

Authors:  Ankur Gupta; Rashmi Karki; Himanshu R Dandu; Kuldeep Dhama; Madan Lb Bhatt; Shailendra K Saxena
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452

Review 8.  Immunotherapeutic approaches to curtail COVID-19.

Authors:  Hajar Owji; Manica Negahdaripour; Nasim Hajighahramani
Journal:  Int Immunopharmacol       Date:  2020-08-21       Impact factor: 4.932

Review 9.  Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.

Authors:  Samuel A Cohen; Caitlyn Kellogg; Ozlem Equils
Journal:  Hum Vaccin Immunother       Date:  2020-07-17       Impact factor: 3.452

Review 10.  Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy?

Authors:  Diego Fernández-Lázaro; Jerónimo J González-Bernal; Nerea Sánchez-Serrano; Lourdes Jiménez Navascués; Ana Ascaso-Del-Río; Juan Mielgo-Ayuso
Journal:  Int J Environ Res Public Health       Date:  2020-11-17       Impact factor: 3.390
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.